Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1

Journal of Inherited Metabolic Disease

Volumn 37, Issue 1, 2014, Pages 83-92

  Cologna, Stephanie M ^a   Cluzeau, Celine V M ^a   Yanjanin, Nicole M ^a   Blank, Paul S ^a   Dail, Michelle K ^a   Siebel, Stephan ^a   Toth, Cynthia L ^a   Wassif, Christopher A ^a   Lieberman, Andrew P ^b   Porter, Forbes D ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; MIGLUSTAT; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NIEMANN PICK DISEASE; NIEMANN PICK DISEASE TYPE C1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; UPREGULATION;

1-DEOXYNOJIRIMYCIN; ADOLESCENT; ALLELES; ANIMALS; BIOLOGICAL MARKERS; BRAIN; CEREBELLUM; CEREBRAL CORTEX; CHEMOKINE CCL3; CHEMOKINE CXCL5; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; INTERLEUKINS; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NIEMANN-PICK DISEASE, TYPE C; YOUNG ADULT;

EID: 84891809529     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-013-9610-6     Document Type: Article

References (53)

1. Aqul A, Liu B, Ramirez CM et al (2011) Unesterified cholesterol accumulation in late endosomes/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment. J Neurosci 31(25):9404-9413
2. Baudry M, Yao Y, Simmons D, Liu J, Bi X (2003) Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia. Exp Neurol 184(2):887-903
3. Carstea ED, Morris JA, Coleman KG et al (1997) Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277(5323):228-231
4. Chabot S, Williams G, Hamilton M, Sutherland G, Yong VW (1999) Mechanisms of IL-10 production in human microglia-T cell interaction. J Immunol 162(11):6819-6828
5. Davidson CD, Ali NF, Micsenyi MC et al (2009) Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One 4(9):e6951
6. Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25(9-10):1439-1451
7. Fu R, Yanjanin NM, Bianconi S, Pavan WJ, Porter FD (2010) Oxidative stress in Niemann-Pick disease, type C. Mol Genet Metab 101(2-3):214-218
8. Ganser GH, Hewett P (2010) An accurate substitution method for analyzing censored data. J Occup Environ Hyg 7(4):233-244
9. Graeber MB, Li W, Rodriguez ML (2011) Role of microglia in CNS inflammation. FEBS Lett 585(23):3798-3805
10. Henry CJ, Huang Y, Wynne AM, Godbout JP (2009) Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun 23(3):309-317
11. Klein A, Maldonado C, Vargas LM et al (2011) Oxidative stress activates the c-Abl/p73 proapoptotic pathway in Niemann-Pick type C neurons. Neurobiol Dis 41(1):209-218
12. Kunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, Kinne RW (2004) Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 63(7):774-784
13. Langmade SJ, Gale SE, Frolov A et al (2006) Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci USA 103(37):13807-13812
14. Li H, Repa JJ, Valasek MA et al (2005) Molecular, anatomical, and biochemical events associated with neurodegeneration in mice with Niemann-Pick type C disease. J Neuropathol Exp Neurol 64(4):323-333
15. Liao G, Wen Z, Irizarry K et al (2010) Abnormal gene expression in cerebellum of Npc1-/- mice during postnatal development. Brain Res 1325:128-140
16. Liu B, Ramirez CM, Miller AM, Repa JJ, Turley SD, Dietschy JM (2010) Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid. J Lipid Res 51(5):933-944
17. Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM (2009) Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse. Proc Natl Acad Sci USA 106(7):2377-2382
18. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408
19. Loftus SK, Morris JA, Carstea ED et al (1997) Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 277(5323):232-235
20. Lopez ME, Klein AD, Hong J, Dimbil UJ, Scott MP (2012a) Neuronal and epithelial cell rescue resolves chronic systemic inflammation in the lipid storage disorder Niemann-Pick C. Hum Mol Genet 21(13):2946-2960
21. Lopez ME, Klein AD, Scott MP (2012b) Complement is dispensable for neurodegeneration in Niemann-Pick disease type C. J Neuroinflamm 9(1):216
22. Love S, Bridges LR, Case CP (1995) Neurofibrillary tangles in Niemann-Pick disease type C. Brain 118(Pt 1):119-129
23. Marin-Teva JL, Cuadros MA, Martin-Oliva D, Navascues J (2012) Microglia and neuronal cell death. Neuron Glia Biol 7(1):25-40.
24. Ong WY, Kumar U, Switzer RC et al (2001) Neurodegeneration in Niemann-Pick type C disease mice. Exp Brain Res 141(2):218-231
25. Park KW, Lee DY, Joe EH, Kim SU, Jin BK (2005) Neuroprotective role of microglia expressing interleukin-4. J Neurosci Res 81(3):397-402
26. Parra J, Klein AD, Castro J et al (2011) Npc1 deficiency in the C57BL/6J genetic background enhances Niemann-Pick disease type C spleen pathology. Biochem Biophys Res Commun 413(3):400-406
27. Patterson MC, Vecchio D, Jacklin E et al (2010) Long-term miglustat therapy in children with Niemann-Pick disease type C. J Child Neurol 25(3):300-305
28. Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE (2007) Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol 6(9):765-772
29. Pentchev PG, Comly ME, Kruth HS et al (1987) Group C Niemann-Pick disease: faulty regulation of low-density lipoprotein uptake and cholesterol storage in cultured fibroblasts. FASEB J 1(1):40-45
30. Pineda M, Wraith JE, Mengel E et al (2009) Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab 98(3):243-249
31. Porter FD, Scherrer DE, Lanier MH et al (2010) Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Trans Med 2(56):56ra81
32. Pressey SN, Smith DA, Wong AM, Platt FM, Cooper JD (2012) Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice. Neurobiol Dis 45(3):1086-1100
33. Ramirez CM, Liu B, Taylor AM et al (2010) Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life. Pediatr Res 68(4):309-315
34. Ransohoff RM, Brown MA (2012) Innate immunity in the central nervous system. J Clin Invest 122(4):1164-1171
35. Reddy JV, Ganley IG, Pfeffer SR (2006) Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling. PLoS One 1:e19
36. Repa JJ, Li H, Frank-Cannon TC et al (2007) Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J Neurosci 27(52):14470-14480
37. Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflammatory process in Alzheimer's disease, role of cytokines. SciWorld J 2012:756357
38. Sarna JR, Larouche M, Marzban H, Sillitoe RV, Rancourt DE, Hawkes R (2003) Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease. J Comp Neurol 456(3):279-291
39. Smith D, Wallom KL, Williams IM, Jeyakumar M, Platt FM (2009) Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1. Neurobiol Dis 36(2):242-251
40. Stein VM, Crooks A, Ding W et al (2012) Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C. J Neuropathol Exp Neurol 71(5):434-448
41. Suk K (2010) Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers. Expert Rev proteomics 7(2):263-274
42. Suzuki K, Parker CC, Pentchev PG et al (1995) Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol 89(3):227-238
43. Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5:16
44. Vanier MT, Millat G (2003) Niemann-Pick disease type C. Clin Genet 64(4):269-281
45. Vazquez MC, Del Pozo T, Robledo FA et al (2011) Alteration of gene expression profile in niemann-pick type C mice correlates with tissue damage and oxidative stress. PLoS One 6(12):e28777
46. Veerhuis R, Nielsen HM, Tenner AJ (2011) Complement in the brain. Mol Immunol 48(14):1592-1603
47. Ward S, O'Donnell P, Fernandez S, Vite CH (2010) 2-hydroxypropyl-beta- cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease. Pediatr Res 68(1):52-56
48. Wraith JE, Vecchio D, Jacklin E et al (2010) Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Mol Genet Metab 99(4):351-357
49. Wu YP, Mizukami H, Matsuda J, Saito Y, Proia RL, Suzuki K (2005) Apoptosis accompanied by up-regulation of TNF-alpha death pathway genes in the brain of Niemann-Pick type C disease. Mol Genet Metab 84(1):9-17
50. Wu YP, Proia RL (2004) Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci USA 101(22):8425-8430
51. Yanjanin NM, Velez JI, Gropman A et al (2010) Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet 153B(1):132-140
52. Zampieri S, Mellon SH, Butters TD et al (2009) Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone. J Cell Mol Med 13(9B):3786-3796
53. Zervas M, Dobrenis K, Walkley SU (2001) Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 60(1):49-64